388 related articles for article (PubMed ID: 25673747)
1. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.
Indersmitten T; Tran CH; Cepeda C; Levine MS
J Neurophysiol; 2015 Apr; 113(7):2953-66. PubMed ID: 25673747
[TBL] [Abstract][Full Text] [Related]
2. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.
Cummings DM; Cepeda C; Levine MS
ASN Neuro; 2010 Jun; 2(3):e00036. PubMed ID: 20585470
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease.
Goodliffe J; Rubakovic A; Chang W; Pathak D; Luebke J
PLoS One; 2020; 15(6):e0234394. PubMed ID: 32574176
[TBL] [Abstract][Full Text] [Related]
4. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
[TBL] [Abstract][Full Text] [Related]
5. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
Barry J; Akopian G; Cepeda C; Levine MS
J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
[TBL] [Abstract][Full Text] [Related]
6. Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.
Holley SM; Galvan L; Kamdjou T; Cepeda C; Levine MS
Eur J Neurosci; 2019 Jan; 49(1):79-93. PubMed ID: 30472747
[TBL] [Abstract][Full Text] [Related]
7. Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.
Goodliffe JW; Song H; Rubakovic A; Chang W; Medalla M; Weaver CM; Luebke JI
PLoS One; 2018; 13(8):e0200626. PubMed ID: 30118496
[TBL] [Abstract][Full Text] [Related]
8. Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice.
Rothe T; Deliano M; Wójtowicz AM; Dvorzhak A; Harnack D; Paul S; Vagner T; Melnick I; Stark H; Grantyn R
Neuroscience; 2015 Dec; 311():519-38. PubMed ID: 26546830
[TBL] [Abstract][Full Text] [Related]
9. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Cepeda C; Hurst RS; Calvert CR; Hernández-Echeagaray E; Nguyen OK; Jocoy E; Christian LJ; Ariano MA; Levine MS
J Neurosci; 2003 Feb; 23(3):961-9. PubMed ID: 12574425
[TBL] [Abstract][Full Text] [Related]
10. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
11. Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.
Li L; Murphy TH; Hayden MR; Raymond LA
J Neurophysiol; 2004 Nov; 92(5):2738-46. PubMed ID: 15240759
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
Klapstein GJ; Fisher RS; Zanjani H; Cepeda C; Jokel ES; Chesselet MF; Levine MS
J Neurophysiol; 2001 Dec; 86(6):2667-77. PubMed ID: 11731527
[TBL] [Abstract][Full Text] [Related]
13. Enhanced striatopallidal gamma-aminobutyric acid (GABA)
Perez-Rosello T; Gelman S; Tombaugh G; Cachope R; Beaumont V; Surmeier DJ
Mov Disord; 2019 May; 34(5):684-696. PubMed ID: 30726572
[TBL] [Abstract][Full Text] [Related]
14. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Cummings DM; André VM; Uzgil BO; Gee SM; Fisher YE; Cepeda C; Levine MS
J Neurosci; 2009 Aug; 29(33):10371-86. PubMed ID: 19692612
[TBL] [Abstract][Full Text] [Related]
15. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
Buren C; Parsons MP; Smith-Dijak A; Raymond LA
Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
[TBL] [Abstract][Full Text] [Related]
16. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.
Kolodziejczyk K; Raymond LA
Neurobiol Dis; 2016 Feb; 86():62-74. PubMed ID: 26621114
[TBL] [Abstract][Full Text] [Related]
17. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
[TBL] [Abstract][Full Text] [Related]
18. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
[TBL] [Abstract][Full Text] [Related]
19. Early TNF-Dependent Regulation of Excitatory and Inhibitory Synapses on Striatal Direct Pathway Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease.
Chambon J; Komal P; Lewitus GM; Kemp GM; Valade S; Adaïdi H; Al Bistami N; Stellwagen D
J Neurosci; 2023 Jan; 43(4):672-680. PubMed ID: 36517241
[TBL] [Abstract][Full Text] [Related]
20. Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Cepeda C; Galvan L; Holley SM; Rao SP; André VM; Botelho EP; Chen JY; Watson JB; Deisseroth K; Levine MS
J Neurosci; 2013 Apr; 33(17):7393-406. PubMed ID: 23616545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]